53691-94-4

Upstream product

• 33358-35-9 (4-methyl-2-nitro-phenyl)-phenylsulfide 
• 108-44-1 1-amino-3-methylbenzene 
• 882-33-7 diphenyldisulfane 
• 89-60-1 1-chloro-4-methyl-2-nitro-benzene 
• 930-69-8 sodium thiophenolate 
• 5326-34-1 4-Bromo-3-nitrotoluene 
• 108-98-5 thiophenol 
• 57076-51-4 2-Nitro-4-methylphenyl-trifluoracetat 
• 119-33-5 4-methyl-2-nitrophenol 

Downstream Products

• 1076222-50-8 (7-methyl-[1,8]naphthyridin-4-yl)-(5-methyl-2-phenylsulfanylphenyl)-amine hydrochloride 
• 1365920-50-8 C₂₃H₂₀N₂S 
• 944642-35-7 C₂₁H₁₈N₄S 
• 944504-42-1 C₂₂H₂₀N₄S 
• 944504-08-9 C₂₃H₂₂N₄S 
• 1365921-39-6 C₂₃H₂₂N₄S 
• 944503-96-2 (7-cyclopropyl-pyrido[2,3-d]pyrimidin-4-yl)-(5-methyl-2-phenylsulfanyl-phenyl)-amine 
• 1451261-72-5 N-[5-methyl-2-(phenylsulfinyl)phenyl]-1-benzofuran-2-sulfonamide 
• 1451261-73-6 N-[5-methyl-2-(phenylsulfonyl)phenyl]-1-benzofuran-2-sulfonamide 
• 1451261-71-4 N-[5-methyl-2-(phenylsulfanyl)phenyl]-1-benzofuran-2-sulfonamide 
• 37930-77-1 5-Methyl-2-phenylthio-trifluormethansulfonanilid 

Relevant academic research and scientific papers

BENZOFURAN-2-SULFONAMIDES DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS

The present invention relates to novel benzofuran-2-sulfonamide derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors.

Novel Hepatitis C virus replicon inhibitors: Synthesis and structure-activity relationships of fused pyrimidine derivatives

The synthesis of several pyrido[2,3-d]pyrimidine and pyrimido[4,5-d] pyrimidine analogs is described with one such analog possessing subnanomolar potency in both genotype 1a and 1b cell culture HCV replicon assays.

FeF3/i2-catalyzed synthesis of 4-chalcogen- substituted arylamines by direct thiolation of an arene C-H bond

An efficient regioselective synthesis of 4-chalcogen-substituted-arylamines by FeF3-catalyzed sulfenylation and selenation of arylamines has been developed. In the presence of FeF3and I2, a variety of arylamines underwent the reaction with disulfides or diselenides to afford the corresponding 4-sulfenyl-or 4-selenenyl-arylamines in moderate to good yields. Georg Thieme Verlag Stuttgart.

ANTI-VIRAL COMPOUNDS

Compounds effective in inhibiting replication of Hepatitis C virus ( HCV ) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, coformulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.